Search Results

You are looking at 1 - 10 of 16 items for :

  • Pharmacy, other x
Clear All
Open access

Špela Zupančič

B (2015) 584–591; https://doi.org/10.1016/j.jconrel.2015.09.008 13. D. H. Reneker and A. L. Yarin, Electrospinning jets and polymer nanofibers, Polymer 49 (2008) 2387–2425; https://doi.org/10.1016/j.polymer.2008.02.002 14. Š. Zupančič, S. Sinha-Ray, S. Sinha-Ray, J. Kristl and A. L. Yarin, Long-term sustained ciprofloxacin release from PMMA and hydrophilic polymer blended nanofibers, Mol. Pharm . 13 (2016) 295–305; https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.5b00804 15. A. V. Bazilevsky, A. L. Yarin and C. M. Megaridis, Co

Open access

E. E. Itoandon, V. A. Nwachukwu, O. L. Erukainure, O. O. Lasore and P. N. Nwagala

] American Cancer Society (ACS). Body weight and cancer risk. 2015, www.cancer.org. Accessed December 23, 2015 [5] Asif M. A brief study of toxic effects of some medicinal herbs on kidney. Adv Biomed Res. 2012, 1: 44. [6] Burkil, H.M., 1985. Royal Botanic Gardens; Kew. [7] Chowdhury P, Soulsby M. Lipid peroxidation in rat brain is increased by simulated weightlessness and decreased by a soyprotein diet. Ann Clin Lab Sci. 2002, 32 (2): 188-192. [8] Cunha LCS, de Morais SAL, Martins CHG, Martins MM, Chang R, de

Open access

Anurag Verma, Ashok Bansal, Amitava Ghosh and Jayanta Pandit

References N. Bhattarai, J. Gunn and M. Zhang, Chitosan-based hydrogels for controlled, localized drug delivery, Adv. Drug Del. Rev.   62 (2010) 83-99; DOI: 10.1016/j.addr.2009.07.019. E. R. Gariépy and J. C. Leroux, Chitosan: A Natural Polycation with Multiple Applications , in Polysaccharides for Drug Delivery and Pharmaceutical Applications (Eds. R. H. Marchessault, F. Ravenelle and X. X. Zhu), ACS Symposium Series , Vol. 934, Washington 2006, pp. 243-259; DOI: 10.1021/bk-2006-0934.ch012

Open access

Blandina Bernal-Morales, Gabriel Guillén-Ruiz, Jonathan Cueto-Escobedo, Juan Francisco Rodríguez-Landa and Carlos M. Contreras

depression-like behavior, ACS Chem. Neurosci . 8 (2017) 955–960; https://doi:10.1021/acschemneuro.7b00042 15. M. G. Craske and M. B. Stein, Anxiety, Lancet 388 (2016) 3048–3059; https://doi.org/10.1016/S0140-6736(16)30381-6

Open access

Londiwe Simphiwe Mbatha, Fiona Chepkoech Maiyo and Moganavelli Singh

of bioreducible cationic polymers with gold nanoparticles for improving stability in serum and application on nonviral gene delivery, ACS Appl. Mater. Inter. 7 (2015) 7724–7731; https://doi.org/10.1021/acsami.5b00732 19. N. Lewinski, V. Colvin and R. Drezek. Cytotoxicity of nanoparticles, Smal. 4 (2008) 26–49; https://doi.org/10.1002/smll.200700595 20. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde and M. Sastry, Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview

Open access

Ahmed Mostafa and Heba Shaaban

and R. Tauler, Untargeted comprehensive two-dimensional liquid chromatography coupled with high-resolution mass spectrometry analysis of rice metabolome using multivariate curve resolution, Anal. Chem . 89 (2017) 7675–7683; https://doi.org/10.1021/acs.analchem.7b01648 16. D. A. Forchetti and R. J. Poppi, Use of NIR hyperspectral imaging and multivariate curve resolution (MCR) for detection and quantification of adulterants in milk powder, LWT-Food Sci. Technol . 76 (2017) 337–343; https://doi.org/10.1016/j.lwt.2016.06.046 17. F. Puig-Castellví, I

Open access

Eman M. Flefel, Randa E. Abdel-Mageid, Waled A. Tantawy, Mohamed A. Ali and Abd El-Galil E. Amr

S. Yoon, 1,3-Diphenyl-1 H -pyrazole derivatives as a new series of potent PPARg partial agonists, Bioorg. Med. Chem. 18 (2010) 8315-8323; DOI: 10.1016/j.bmc.2010.09.068. 6. A. Mohammad, K. Harish and S. A. Javed, Pharmacological activities of pyrazole and its derivatives , Hamdard Medicus 52 (2009) 102-118. 7. A. El Maatougui, J. Azuaje, E. Sotelo, O. Caamaño and A. Coelho, Silica-supported aluminum chloride-assisted solution phase synthesis of pyridazinone-based antiplatelet agents , ACS Comb. Sci. 10 (2011) 7

Open access

Mir-Ali Molaei, Karim Osouli-Bostanabad, Khosro Adibkia, Javad Shokri, Solmaz Asnaashari and Yousef Javadzadeh

. Vodak, Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations, Mol. Pharm. 14 (2017) 2032–2046; https://doi.org/10.1021/acs.molpharmaceut.7b00121 21. J. Bassi da Silva, S. B. d. S. Ferreira, O. de Freitas and M. L. Bruschi, A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems, Drug Dev. Ind. Pharm. 43 (2017) 1053–1070; https://doi.org/10.1080/03639045.2017.1294600 22. A. Ruff, T. Fiolka and E. S. Kostewicz

Open access

R. Mikláš, N. Miklášová, M. Bukovský and F. Devínsky

Targeting Isoprenoid Biosynthesis. ACS Med Chem Lett. 2013;4:423-427. [35] Zhi DF, Zhang SB, Qureshi F et al. Synthesis and biological activity of carbamate-linked cationic lipids for gene delivery in vitro. Bioorg Med Chem Lett. 2012;22(11):3837-3841. [36] Zinchenko AA, Sergeyev VG, Yamabe K, Murata S, Yoshikawa K. DNA compaction by divalent cations: structural specificity revealed by the potentiality of designed quaternary diammonium salts. Chembiochem 2004;5:360-368.

Open access

Tina Ukmar and Odon Planinšek

nanoparticles for imaging, targeting, and drug delivery, ACS Nano   2 (2008) 889-896; DOI: 10.1021/nn800072t. R. Mellaerts, R. Mols, J. A. G. Jammaer, C. A. Aerts, P. Annaert, J. V. Humbeeck, G. Van den Mooter, P. Augustijns and J. A. Martens, Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica, Eur. J. Pharm. Biopharm.   69 (2008) 223-230; DOI: 10.1016/j.ejpb.2007.11.006. V. Ambrogia, L. Perioli, F. Marmottinib, S. Giovagnolia, M. Espositoa and C. Rossia